Johnson & Johnson (JNJ) Ends Mid-Stage Eczema Study After Missing Efficacy Bar

Johnson & Johnson (NYSE:JNJ) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 26, Johnson & ...
health enews

Dry skin vs. eczema: Why it’s important to know the difference

Eczema is a common skin condition that causes itchiness, burning and dryness. Dry skin occurs when your skin loses too much ...
Vietnam Investment Review

Eczema causes festive isolation for some Singaporeans during gatherings

Skin condition flare-ups during the humid season are leading some individuals to avoid social events and celebrations.

Why winter in the UAE is tough on dry skin—and how to fix it

While mild sunshine may tempt you to keep the same summer routine, dermatologists warn that winter requires a careful shift ...
The Malaysian Reserve

Festive Season Isolation: How Eczema Is Keeping Singaporeans From Gatherings

Medical Channel Asia's ongoing eczema survey reveals how chronic itch drives withdrawal, emotional strain, and missed celebrations during a period ...
Stocktwits on MSN

Johnson & Johnson terminates experimental eczema drug study after it fails to show benefit

The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...
Healio

Nemluvio relieves itch, sleep loss ‘as early as 2 days’ in eczema, prurigo nodularis

Nemolizumab, which targets the interleukin-31 pathway, rapidly improves itch and sleep in people with atopic dermatitis and ...

Johnson & Johnson halts mid-stage trial of experimental eczema drug

Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...